| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.27 | 0.06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.08 | 0.07 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.07 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |